Cover
Cover | Mar. 09, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Mar. 9, 2022 |
Entity Registrant Name | Keros Therapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-39264 |
Entity Tax Identification Number | 81-1173868 |
Entity Address, Address Line One | 99 Hayden Avenue |
Entity Address, Address Line Two | Suite 120 |
Entity Address, Address Line Three | Building E |
Entity Address, City or Town | Lexington |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02421 |
City Area Code | 617 |
Local Phone Number | 314-6297 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.0001 par value per share |
Trading Symbol | KROS |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Central Index Key | 0001664710 |
Amendment Flag | false |